Fig 3.TIF (674.82 kB)

Mean (±SD) plasma concentration.

figure

posted on 2016-09-15, 17:30 authored by Jörg Täubel, Georg Ferber, Sara Fernandes, Ulrike Lorch, Eva Santamaría, Iñaki Izquierdo

Profiles of rupatadine over time (A), UR-12790 (desloratadine) (B) and UR-12788 (3-hydroxydesloratadine) (C) following administration of single and multiple doses of rupatadine (10, 20 and 40 mg) on Days 1 and 5.

History

Usage metrics

Keywords

PK-PD dose Cognitive Function Profile RT SAE RVP VAS rupatadine safety PD PK Japanese subjects Randomised Placebo-Controlled Trial Introduction Rupatadine 40 mg AUC SWM TEAE CNS

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM